No evidence of a higher 10 year period prevalence of diabetes among 77,885 twins compared with 215,264 singletons from the Danish birth cohorts 1910-1989.

AIMS/HYPOTHESIS: Previous Danish twin studies have found a highly increased risk of precursors of type 2 diabetes as well as a higher prevalence of type 2 diabetes among twins compared with singletons. Likewise, small-scale studies of Danish twins have shown that monozygotic twins have a higher risk of developing precursors of type 2 diabetes compared with dizygotic twins. In the present register-based study, the 10 year period diabetes prevalence in Danish twins is compared with that in a random sample of Danish citizens. Furthermore, the 10 year period prevalence of diabetes in monozygotic twins is compared with that in dizygotic twins. METHODS: The study population consisted of twins (n = 77,885) identified in the Danish Twin Registry, and a 5% random sample (n = 215,264) from the birth cohorts 1910-1989. We identified diabetes patients by means of three nationwide Danish health registers. RESULTS: The number of identified diabetes cases among males was 6,677 (6.24%) for singletons vs 2,271 (5.68%) for twins (difference = 0.56% [0.29-0.83%]). The number among females was 6,143 (5.67%) for singletons and 1,722 (4.54%) for twins (difference = 1.13% [0.88-0.38%]). Restriction to various birth cohorts, known zygosity and known type 2 diabetes did not alter the overall conclusions. The difference between monozygotic twins (males, 5.29%; females, 4.40%) and dizygotic twins (males, 5.77%; females, 4.63%) was non-significant. CONCLUSIONS/INTERPRETATION: Danish twins do not have an increased risk of developing diabetes compared with singletons, and the risk of diabetes among monozygotic twins does not differ from that of dizygotic twins.

Radiographic absorptiometry as a screening tool in male osteoporosis: results from the Odense Androgen Study.

BACKGROUND: Osteoporosis screening with dual-energy absorptiometry (DXA) is not recommended due to low diagnostic utility and costs. Radiographic absorptiometry (RA) determines bone mineral density (BMD) of the phalangeal bones of the hand and is a potential osteoporosis pre-screening tool. PURPOSE: To determine the ability of RA to identify patients with osteoporosis in a male population. MATERIAL AND METHODS: As part of the Odense Androgen Study, we measured BMD of the intermediate phalanges of the second to fourth finger, lumbar spine (L2-L4), and total hip in 218 men aged 60-74 years (mean 68.8 years), randomly invited from the population, using RA (MetriScan) and DXA (Hologic 4500-A). Osteopenia and osteoporosis were defined as a T-score of less than -1.0 and -2.5, respectively, in the hip and/or lumbar spine. Receiver operating characteristic (ROC) curves and area under the curve (AUC) were computed. RESULTS: BMD(RA) of the phalanges correlated significantly with BMD(DXA) of the hip (R=0.47, P<0.001) and lumbar spine (R=0.46, P<0.001). A total of 105 men (48.2%) were osteopenic and 15 (6.9%) osteoporotic. The AUC (SE) value for detecting osteoporosis was 0.75 (0.06). The sensitivity and specificity of RA in identifying osteoporosis were 0.93 and 0.50, respectively. CONCLUSION: BMD(RA) correlated weakly with BMD(DXA) of the lumbar spine and total hip, and RA has a moderate ability to identify osteoporotic individuals. Nevertheless, RA may be used as a pre-screening tool in men, since the diagnosis may be ruled out in half the population at little cost.